GlassScriptPhysician profile
Nelson A Clara
NPI 1699775361
$1,844.57
in general payments reported to CMS, 2019-2025
10 companies · $248 in 2025
The $248 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $80.89 · 2022: $389 · 2023: $651 · 2024: $475 · 2025: $248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,374.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,080.99 | 2022-2025 | Endurant Iis, Corevalve Evolut R, Cardioblate |
| Atricure, INC. | $434.92 | 2024-2025 | Synergy Ablation System |
| Smith+Nephew, INC. | $78.43 | 2022-2024 | Pico 7, Pico 14, Renasys Touch |
| Cook Medical LLC | $70.63 | 2024 | Zilver Ptx |
| W. L. Gore & Associates, INC. | $65.79 | 2021-2024 | Gore Viabahn Vbx Balloon Expandable Endo |
| Bard Peripheral Vascular, INC. | $33.90 | 2021 | |
| Ossur Americas, INC. | $23.58 | 2025 | |
| Integra Lifesciences Corporation | $19.98 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $19.97 | 2024 | Exparel |
| Convatec INC. | $16.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nelson Clara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.